Bay Colony Advisory Group, Inc D Exact Sciences Corp Transaction History

Bay Colony Advisory Group, Inc D

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 01, 2023	BUY	$30.35 - $53.15 $125,952 - $220,572	4,150 New	4,150 $205,000
Q1 2020 Apr 17, 2020	SELL	$37.9 - $104.44 $170,550 - $469,980	-4,500 Closed	0 $0
Q4 2019 Jan 28, 2020	BUY	$77.66 - $99.74 $349,470 - $448,830	4,500 New	4,500 $427,000
Q4 2019 Jan 28, 2020	SELL	$77.66 - $99.74 $419,364 - $538,596	-5,400 Closed	0 $0
Q3 2019 Oct 25, 2019	BUY	$90.37 - $122.49 $487,998 - $661,446	5,400 New	5,400 $488,000

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Bay Colony Advisory Group, Inc D, based on Form 13F filings with the SEC.

Stay updated on Bay Colony Advisory Group, Inc D with notifications on news.